In human colon cancer HT-29 cells, luteolin treatment triggered the release of cytochrome c from mitochondria into the cytoplasm, leading to increased levels of activated caspase-9 and caspase-3 (Raina et al., 2021). Here, CASP9 is linked to colonic neoplasm.